Teva Pharmaceutical Industries shares owned by Natixis Asset Management Advisors
Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Natixis Asset Management Advisors
from 13F filings
Historical chart of Natixis Asset Management Advisors investment in Teva Pharmaceutical Industries
Tip: Access up to 7 years of quarterly data
All positions including Teva Pharmaceutical Industries held by Natixis Asset Management Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Teva Pharmaceutical Industries by Natixis Asset Management Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.5M | 274k | 20.20 |
| 2025-06-30 | $6.5M | 385k | 16.76 |
| 2025-03-31 | $5.1M | 333k | 15.37 |
| 2024-12-31 | $11M | 505k | 22.04 |
| 2024-09-30 | $3.0M | 169k | 18.02 |
| 2024-06-30 | $3.3M | 201k | 16.25 |
| 2024-03-31 | $2.2M | 158k | 14.11 |
| 2016-12-31 | $2.7M | 76k | 36.20 |
| 2016-09-30 | $4.0M | 87k | 45.98 |
| 2016-06-30 | $5.0M | 100k | 50.33 |
| 2016-03-31 | $7.7M | 145k | 53.33 |
| 2015-12-31 | $9.3M | 142k | 65.62 |
| 2015-09-30 | $10M | 179k | 56.46 |
| 2015-06-30 | $15M | 257k | 59.12 |
| 2015-03-31 | $16M | 260k | 62.31 |
| 2014-12-31 | $13M | 231k | 57.53 |
| 2014-09-30 | $9.0M | 168k | 53.75 |
| 2014-06-30 | $11M | 212k | 52.43 |
| 2014-03-31 | $8.0M | 152k | 52.84 |
| 2013-12-31 | $6.6M | 165k | 40.08 |
| 2013-09-30 | $6.3M | 167k | 37.77 |
| 2013-06-30 | $6.9M | 176k | 39.21 |
| 2012-12-31 | $5.1M | 138k | 37.33 |
| 2012-09-30 | $10M | 245k | 41.42 |
| 2012-06-30 | $8.9M | 225k | 39.45 |
| 2012-03-31 | $11M | 235k | 45.07 |
| 2011-12-31 | $8.7M | 215k | 40.37 |
| 2011-09-30 | $8.5M | 227k | 37.23 |
| 2011-06-30 | $8.8M | 182k | 48.21 |
| 2010-12-31 | $4.2M | 80k | 52.13 |
More positions owned by Natixis Asset Management Advisors
View all positions for Natixis Asset Management Advisors
Top funds holding Teva Pharmaceutical Industries
View all funds holding Teva Pharmaceutical Industries